Advertisement

The Body PRO covers CROI 2009



  

Complications & Coinfections

David Wohl, M.D. A Review of Cardiovascular Disease and HIV: Highlights From CROI 2009
How significant a problem is cardiovascular disease for HIV-infected patients? Read or listen as David Wohl, M.D., walks us through some of the most important cardiovascular findings presented at CROI 2009. This conference included a few studies that may change the landscape of HIV care: One study, for instance, suggests that HIV is an independent risk factor for atherosclerosis, posing a danger similar to that of traditional cardiovascular disease risk factors. Other studies highlighted critical biomarkers that may be used to assess a patient's cardiovascular risk more effectively than the lipid profiles we currently utilize.
Read or listen (34 min.):
Complications & Coinfections
Jens Lundgren, M.D., and Jeff Berry Jens Lundgren, M.D., Discusses New Findings Regarding MI Risk of Specific Antiretrovirals
The latest data from D:A:D indicate that lopinavir/ritonavir does increase myocardial infarction risk, but efavirenz, nevirapine and tenofovir do not. In this interview, Jens Lundgren, M.D., and HIV advocate Jeff Berry take part in a fascinating discussion on the new findings and their possible underlying causes.
Read or listen (20 min.):
More Top Stories:


Please note: Knowledge about HIV changes rapidly. Note the date of this summary's publication, and before treating patients or employing any therapies described in these materials, verify all information independently. If you are a patient, please consult a doctor or other medical professional before acting on any of the information presented in this summary. For a complete listing of our most recent conference coverage, click here.

  
Advertisement